Wednesday, 6 September 2017

IQE and Optibiotix just won't stop climbing

Yesterday was exciting and I wondered what the rest of the week would throw at us, and today it threw plenty.

IQE:IQE seems unstoppable, climbing another 5.75p and providing £374 (16%) potential profit in the 2 days I've owned them in my SIPP.

That's nothing compared to my ISA holding, which is going crazy and is now making £8,086 (413%) potential profit.

That would be enough to make me deliriously happy on its own, however the OPTI:Optibiotix bid price climbed another 3.5p today. This has gone from Nemesis Share making a loss of £4,500 just a few months ago to £3,374 paper profit today. At this rate of growth it will soon overtake IQE:IQE as Star Share!

The effect on the combined portfolios has seen another significant milestone reached, with the total value passing £80,000. That won't be an official figure unless it lasts until Friday and gets on the snapshot graph, so I just need things to stabilise a bit for the rest of the week.

Still no news following the CAML:Central Asia Metals suspension. I felt obliged to post on their bulletin board:

"CAML has a superb track record of putting shareholders first. Don't forget, they've paid out more in dividends than they generated from the IPO.

I really don't believe they would be considering this unless in the shareholders' best interests.

CAML are a cautious company - as their approach to Copper Bay demonstrates.

I'm more excited about what could be an amazing opportunity than I am nervous about being shafted."


Now I just need to hope it's all true! I'm really hoping this is a buy-out of a bigger company. No corresponding publicly listed companies have had their shares suspended though, so it points to a private company. Just a waiting game now.

This week could easily smash the record of best ever week - but there are still 2 days to go and all sorts of horrors could unfold. Roll on 8am...

No comments:

Post a Comment